Ticker
ABCL

Price
4.49
Stock movement up
+0.15 (3.46%)
Company name
Abcellera Biologics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
1.29B
Ent value
1.21B
Price/Sales
2.66
Price/Book
1.05
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
8.15
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-37.20%
3 year return
-46.30%
5 year return
-
10 year return
-
Last updated: 2024-04-08

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ABCL does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E8.15
Price to OCF4.66
Price to FCF6.31
Price to EBITDA4.75
EV to EBITDA4.46

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.66
Price to Book1.05
EV to Sales2.50

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count287.69M
EPS (TTM)0.50
FCF per share (TTM)0.65

Income statement

Loading...
Income statement data
Revenue (TTM)485.43M
Gross profit (TTM)418.99M
Operating income (TTM)218.19M
Net income (TTM)158.52M
EPS (TTM)0.50
EPS (1y forward)-0.65

Margins

Loading...
Margins data
Gross margin (TTM)86.31%
Operating margin (TTM)44.95%
Profit margin (TTM)32.66%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash386.54M
Net receivables103.41M
Total current assets1.03B
Goodwill47.81M
Intangible assets131.50M
Property, plant and equipment0.00
Total assets1.54B
Accounts payable14.83M
Short/Current long term debt82.26M
Total current liabilities118.32M
Total liabilities307.63M
Shareholder's equity1.23B
Net tangible assets1.05B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)277.36M
Capital expenditures (TTM)72.66M
Free cash flow (TTM)204.70M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity12.85%
Return on Assets10.29%
Return on Invested Capital12.80%
Cash Return on Invested Capital16.52%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.38
Daily high4.54
Daily low4.35
Daily Volume857K
All-time high53.20
1y analyst estimate28.33
Beta-0.09
EPS (TTM)0.50
Dividend per share-
Ex-div date-
Next earnings date7 May 2024

Downside potential

Loading...
Downside potential data
ABCLS&P500
Current price drop from All-time high-91.56%-0.85%
Highest price drop-92.65%-56.47%
Date of highest drop27 Oct 20239 Mar 2009
Avg drop from high-74.11%-11.35%
Avg time to new high167 days13 days
Max time to new high801 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ABCL (Abcellera Biologics Inc) company logo
Marketcap
1.29B
Marketcap category
Small-cap
Description
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Employees
495
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...